Gateway to Think Tanks
来源类型 | Working Paper |
规范类型 | 论文 |
Still Taxed to Death | |
Roger Bate; Richard Tren; Jasson Urbach | |
发表日期 | 2006-02-27 |
出版年 | 2006 |
语种 | 英语 |
摘要 | This paper examines the role that tariffs, domestic taxes, and regulatory requirements pose on access to essential drugs, vaccines and devices for the diseases that afflict the developing world. While aid has increased in recent years and the price of many drugs has fallen, access to medicines, vaccines and devices has not increased greatly. There are numerous reasons for this, notably the paucity of medical professionals in the poorest countries. The major one discussed in this paper is the barrier imposed by recipient countries themselves. For example the combined domestic tax and import tariff barrier in India until recently was over 60% and in Morocco it currently stands at 38%. Only just over a third of Indians have access to essential drugs and it is likely that a reduction of these financial impediments would increase access. Removal of these barriers would therefore likely save thousands of lives across the developing world. Southern African countries generally have fewer tariff barriers. But if South Africa removed its 14% sales tax, HIV patients could afford more food, and many are currently malnourished. Furthermore, many Southern African countries, such as Namibia, impose regulatory constraints (expensive and time consuming registration of products already approved in US/EU), which reduce access to essential medicines. Download the PDF here |
主题 | Health Care |
标签 | AEI Archive ; AEI-Brookings |
URL | https://www.aei.org/research-products/working-paper/still-taxed-to-death/ |
来源智库 | American Enterprise Institute (United States) |
资源类型 | 智库出版物 |
条目标识符 | http://119.78.100.153/handle/2XGU8XDN/206888 |
推荐引用方式 GB/T 7714 | Roger Bate,Richard Tren,Jasson Urbach. Still Taxed to Death. 2006. |
条目包含的文件 | ||||||
文件名称/大小 | 资源类型 | 版本类型 | 开放类型 | 使用许可 | ||
Still_Taxed_to_Death(497KB) | 智库出版物 | 限制开放 | CC BY-NC-SA | 浏览 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。